Richard M. Searfoss

Richard M. Searfoss

Auto-generated profile, based on publicly available information

Richard M. Searfoss

Department of Biochemistry and Molecular Biophysics, Washington University in St. Louis, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
EZEmily Zahn
Emily Zahn
YXYIXUAN XIE
YIXUAN XIE
XLXingyu Liu
Xingyu Liu
RKRashmi Karki
Rashmi Karki
RSRichard M. Searfoss
Richard M. Searfoss
BGBenjamin A. Garcia
Benjamin A. Garcia
Histone post-translational modifications (PTMs) regulate gene expression patterns through epigenetic mechanisms. The five histone proteins (H1, H2A, H2B, H3, and H4) are extensively modified, with over 75 distinct modification types spanning more than 200 sites. Despite strong advances in mass spectrometry (MS)-based approaches, identification and quantification of modified histone peptides remains challenging because of factors, such as isobaric peptides, pseudo-isobaric PTMs, and low stoichiometry of certain marks. Here, we describe the development of a new high-throughput method to identify and quantify over 150 modified histone peptides by LC-MS. Fast gradient microflow liquid chromatography and variable window sequential windows acquisition of all theoretical spectra data-independent acquisition on a new quadrupole time-of-flight platform is compared to a previous method using nanoflow LC-MS on an Orbitrap hybrid. Histones extracted from cells treated with either a histone deacetylase inhibitor or transforming growth factor-beta 1 were analyzed by data-independent acquisition on two mass spectrometers: an Orbitrap Exploris 240 with a 55-min nanoflow LC gradient and the SCIEX ZenoTOF 7600 with a 10-min microflow gradient. To demonstrate the reproducibility and speed advantage of the method, 100 consecutive injections of one sample were performed in less than 2 days on the quadrupole time-of-flight platform. The result is the comprehensive characterization of histone PTMs achieved in less than 20 min of total run time using only 200 ng of sample. Results for drug-treated histone samples are comparable to those produced by the previous method and can be achieved using less than one-third of the instrument time.

25 August 2025 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
Zongtao LinZongtao Lin
Zongtao Lin
YXYIXUAN XIE
YIXUAN XIE
JGJoanna Gongora
Joanna Gongora
XLXingyu Liu
Xingyu Liu
EZEmily Zahn
Emily Zahn
BGBenjamin A. Garcia
Benjamin A. Garcia
Protein arginylation is an essential post-translational modification catalyzed by arginyl-tRNA-protein transferase 1 (ATE1) in mammalian systems. Arginylation features a post-translational conjugation of an arginyl to a protein, making it extremely challenging to differentiate from translational arginine residues with the same mass. Here we present a general ATE1-based arginylation profiling platform for the unbiased discovery of arginylation substrates and their precise modification sites. This method integrates isotopic arginine labeling into an ATE1 assay utilizing biological lysates (ex vivo) rather than live cells, thus eliminating ribosomal bias and enabling bona fide arginylation identification. The method has been successfully applied to peptide, protein, cell, patient and mouse samples, with 235 unique arginylation sites revealed from human proteomes using 20 µg of input. Representative sites were validated and followed up for their biological functions. This global platform, applicable to various sample types, paves the way for functional studies of this difficult-to-characterize protein modification.

26 June 2025 in Analytical Chemistry
Verified
Journal Article
Closed access
RSRichard M. Searfoss
Richard M. Searfoss
XLXingyu Liu
Xingyu Liu
BGBenjamin A. Garcia
Benjamin A. Garcia
Zongtao LinZongtao Lin
Zongtao Lin

24 June 2025 in Analytical Chemistry
Verified
Journal Article
Closed access
CFCassandra N. Fuller
Cassandra N. Fuller
SAShofiul Alam
Shofiul Alam
KFKevin Jeanne Dit Fouque
Kevin Jeanne Dit Fouque
LTLilian Valadares Tose
Lilian Valadares Tose
RSRichard M. Searfoss
Richard M. Searfoss
FFFrancisco Fernandez-Lima
Francisco Fernandez-Lima

17 February 2026 in Research Square
Verified
Preprint
Open access
PDF file
KKKeri-Lyn Kozul
Keri-Lyn Kozul
AAAli AlAsmari
Ali AlAsmari
EAEssa Alharby
Essa Alharby
RZReem Zakzouk
Reem Zakzouk
YYYoumian Yan
Youmian Yan
NANaif Almontashiri
Naif Almontashiri
The mitochondrial phosphatase PPTC7 has emerged as a potent regulator of metabolism and mitophagy as its global knockout leads to perinatal lethality in mice. However, no known Mendelian diseases have been linked to PPTC7 deficiency, rendering its role in human pathophysiology unclear. Here, we identify two independent homozygous variants in PPTC7 : a missense variant, p.D158N, and a duplication variant (c.*57dup) within the 3` untranslated region (UTR). These variants were detected in three patients from two unrelated families presenting with a primary mitochondrial disease characterized by hypomyelinating leukodystrophy, recurrent metabolic and lactic acidosis, and anemia with immune dysregulation. Patient samples, including plasma and primary fibroblasts, showed robust metabolic and mitochondrial dysfunction, with substantial phenotypic overlap with Pptc7 knockout murine fibroblast models. PPTC7 patient fibroblasts carrying the p.D158N variant and CRISPR-knocked in cells to model the 3`UTR variant showed hallmarks of excessive BNIP3- and NIX-mediated mitophagy, including aberrant mitochondrial morphology, diminished mitochondrial protein expression, and increased mt-Keima flux. Critically, increased mitophagy in these cellular models was rescued by exogenous PPTC7 expression, confirming dysfunction derives from loss of this mitochondrial phosphatase. Mechanistically, we found that the p.D158N variant, affecting a highly conserved residue, disrupts metal binding to compromise both the enzymatic phosphatase function of PPTC7 as well as its negative regulation of BNIP3 and NIX. Collectively, these data provide the first known cases with a recessive inborn error of mitophagy due to PPTC7 deficiency and underscore the importance of this mitochondrial phosphatase in maintaining metabolic health and balanced mitophagy.

10 April 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MCMariel Coradin
Mariel Coradin
EPElizabeth G. Porter
Elizabeth G. Porter
FVFrancisca Nathalia de Luna Vitorino
Francisca Nathalia de Luna Vitorino
RSRichard M. Searfoss
Richard M. Searfoss
JCJoseph Cesare
Joseph Cesare
BGBenjamin A. Garcia
Benjamin A. Garcia
Histone proteolysis is an understudied phenomenon in which the N-terminal tails of histones are irreversibly cleaved by intracellular proteases. During development, histone post-translational modifications (PTMs) are known to orchestrate gene expression patterns that ultimately drive cell fate decisions. Therefore, deciphering the mechanisms of histone proteolysis is necessary to enhance the understanding of cellular differentiation. Here, we show that histone H2A is cleaved by the lysosomal protease Cathepsin L during mouse ESC differentiation. Using quantitative mass spectrometry (MS), we identified L23 to be the primary cleavage site that gives rise to the main clipped form of H2A (cH2A), which reaches a maximum level of ∼1% of total H2A after 4 days of ESC differentiation. Using ChIP-seq, we found that preventing proteolysis leads to an increase in acetylated H2A at promoter regions in differentiated ES cells. We also identified novel readers of different acetylated forms of H2A in pluripotent ES cells, such as members of the PBAF remodeling complex, and showed that H2A proteolysis abolishes this recognition. Analysis of the histone H3 PTM profiles of full-length (FL) H2A and cH2A containing nucleosomes demonstrates that cH2A is associated with marks found on active genes, consistent with ChIP-seq experiments. cH2A-containing nucleosomes are also less stable or turned over at faster rates than nucleosomes containing FL H2A. Altogether, our data suggest that proteolysis serves as an efficient mechanism to silence pluripotency genes and destabilize the nucleosome core particle.